Bio-Techne TECH Long-Term Debt
Long-Term Debt at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtAndCapitalLeaseObligations.
The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's long-term debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bio-Techne's long-term debt?
- Bio-Techne (TECH) reported long-term debt of $200M in Q1 2026.
- How has Bio-Techne's long-term debt changed year-over-year?
- Bio-Techne's long-term debt decreased by 39.4% year-over-year, from $330M to $200M.
- What is the long-term trend for Bio-Techne's long-term debt?
- Over 4 years (2021 to 2025), Bio-Techne's long-term debt has grown at a 1.3% compound annual growth rate (CAGR), from $328.83M to $346M.
- What does long-term debt mean?
- The total amount of debt the company owes that is due in more than one year.
- How do you interpret long-term debt?
- An increase may indicate aggressive expansion or acquisition financing, while a decrease suggests debt repayment or deleveraging.
- How does long-term debt compare across companies?
- Peers in the life sciences sector typically maintain moderate debt levels to fund R&D and strategic acquisitions.